Salmon cartilage proteoglycan modulates cytokine responses to Escherichia coli in mouse macrophages

Biochemical and Biophysical Research Communications

Volumn 351, Issue 4, 2006, Pages 1005-1010

  Sashinami, Hiroshi ^a   Takagaki, Keiichi ^a   Nakane, Akio ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

E. coli; IL 10; Macrophage; Proteoglycan; TNF

Indexed keywords

CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; PROTEOGLYCAN; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; CARTILAGE; CELL LINE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; ESCHERICHIA COLI; EXTRACELLULAR MATRIX; HEAT; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOREGULATION; IMMUNOSTIMULATION; MACROPHAGE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; SALMON; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CARTILAGE; CELLS, CULTURED; CHONDROITIN SULFATES; CYTOKINES; ESCHERICHIA COLI; INTERLEUKIN-10; MACROPHAGES; MICE; PHOSPHORYLATION; PROTEOGLYCANS; SALMON; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

ESCHERICHIA COLI; MAMMALIA;

EID: 33750842957     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.10.146     Document Type: Article

References (43)

1. Hook M., Kjellen L., and Johansson S. Cell-surface glycosaminoglycans. Annu. Rev. Biochem. 53 (1984) 847-869
2. Buckwalter J.A., and Rosenberg L.C. Electron microscopic studies of cartilage proteoglycans. Direct evidence for the variable length of the chondroitin sulfate-rich region of proteoglycan subunit core protein. J. Biol. Chem. 257 (1982) 9830-9839
3. Har-el R., and Tanzer M.L. Extracellular matrix. 3: evolution of the extracellular matrix in invertebrates. FASEB J. 7 (1993) 1115-1123
4. Danen E.H., and Yamada K.M. Fibronectin, integrins, and growth control. J. Cell. Physiol. 189 (2001) 1-13
5. Chou M.M., Vergnolle N., McDougall J.J., Wallace J.L., Marty S., Teskey V., and Buret A.G. Effects of chondroitin and glucosamine sulfate in a dietary bar formulation on inflammation, interleukin-1beta, matrix metalloprotease-9, and cartilage damage in arthritis. Exp. Biol. Med. (Maywood) 23 (2005) 255-262
6. Michel B.A., Stucki G., Frey D., De Vathaire F., Vignon E., Bruehlmann P., and Uebelhart D. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. Arthritis Rheum. 52 (2005) 779-786
7. Brown K.E., Leong K., Huang C.H., Dalal R., Green G.D., Haimes H.B., Jimenez P.A., and Bathon J. Gelatin/chondroitin 6-sulfate microspheres for the delivery of therapeutic proteins to the joint. Arthritis Rheum. 41 (1998) 2185-2195
8. Campo G.M., Avenoso A., Campo S., Ferlazzo A.M., Altavilla D., and Calatroni A. Efficacy of treatment with glycosaminoglycans on experimental collagen-induced arthritis in rats. Arthritis Res. Ther. 5 (2003) R122-R131
9. Lider O., Baharav E., Mekori Y.A., Miller T., Naparstek Y., Vlodavsky I., and Cohen I.R. Suppression of experimental autoimmune diseases and prolongation of allograft survival by treatment of animals with low doses of heparins. J. Clin. Invest. 83 (1989) 752-756
10. Lider O., Mekori Y.A., Miller T., Bar-Tana R., Vlodavsky I., Baharav E., Cohen I.R., and Naparstek Y. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Eur. J. Immunol. 20 (1990) 493-499
11. Teder P., Vandivier R.W., Jiang D., Liang J., Cohn L., Pure E., Henson P.M., and Noble P.W. Resolution of lung inflammation by CD44. Science 296 (2002) 155-158
12. Termeer C.C., Hennies J., Voith U., Ahrens T., Weiss J.M., Prehm P., and Simon J.C. Oligosaccharides of hyaluronan are potent activators of dendritic cells. J. Immunol. 165 (2000) 1863-1870
13. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., and Simon J.C. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195 (2002) 99-111
14. He Y.W., Li H., Zhang J., Hsu C.L., Lin E., Zhang N., Guo J., Forbush K.A., and Bevan M.J. The extracellular matrix protein mindin is a pattern-recognition molecule for microbial pathogens. Nat. Immunol. 5 (2004) 88-97
15. Comalada M., Cardo M., Xaus J., Valledor A.F., Lloberas J., Ventura F., and Celada A. Decorin reverses the repressive effect of autocrine-produced TGF-β on mouse macrophage activation. J. Immunol. 170 (2003) 4450-4456
16. Schaefer L., Babelova A., Kiss E., Hausser H.J., Baliova M., Krzyzankova M., Marsche G., Young M.F., Mihalik D., Gotte M., Malle E., Schaefer R.M., and Grone H.J. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115 (2005) 2223-2233
17. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., and Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 162 (1999) 3749-3752
18. Buchmeier N.A., and Schreiber R.D. Requirement of endogenous interferon-γ production for resolution of Listeria monocytogenes infection. Proc. Natl. Acad. Sci. USA 82 (1985) 7404-7408
19. Nathan C.F., Murray H.W., Wiebe M.E., and Rubin B.Y. Identification of interferon-γ as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J. Exp. Med. 158 (1983) 670-689
20. Bao S., Beagley K.W., France M.P., Shen J., and Husband A.J. Interferon-γ plays a critical role in intestinal immunity against Salmonella typhimurium infection. Immunology 99 (2000) 464-472
21. Gulig P.A., Doyle T.J., Clare-Salzler M.J., Maiese R.L., and Matsui H. Systemic infection of mice by wild-type but not Spv- Salmonella typhimurium is enhanced by neutralization of gamma interferon and tumor necrosis factor alpha. Infect. Immun. 65 (1997) 5191-5197
22. Nauciel C., and Espinasse-Maes F. Role of gamma interferon and tumor necrosis factor alpha in resistance to Salmonella typhimurium infection. Infect. Immun. 60 (1992) 450-454
23. Nakane A., Minagawa T., and Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect. Immun. 56 (1988) 2563-2569
24. Bogdan C., Vodovotz Y., and Nathan C. Macrophage deactivation by interleukin 10. J. Exp. Med. 174 (1991) 1549-1555
25. Moore K.W., O'Garra A., de Waal Malefyt R., Vieira P., and Mosmann T.R. Interleukin-10. Annu. Rev. Immunol. 11 (1993) 165-190
26. Lee T.S., and Chau L.Y. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat. Med. 8 (2002) 240-246
27. Riley J.K., Takeda K., Akira S., and Schreiber R.D. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J. Biol. Chem. 274 (1999) 16513-16521
28. Tripp C.S., Wolf S.F., and Unanue E.R. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90 (1993) 3725-3729
29. Majima M., Takagaki K., Sudo S., Yoshihara S., Kudo Y., and Yamagishi S. Effect of Proteoglycan on Experimental Colitis, in New Developments in Glycomedicine. In: Endo M., Harata S., Saito Y., Munakata A., Sasaki M., and Tsuchida S. (Eds) (2001), Elsevier Science B.V., Amsterdam, the Netherlands 221-224
30. Nakane A., Nishikawa S., Sasaki S., Miura T., Asano M., Kohanawa M., Ishiwata K., and Minagawa T. Endogenous interleukin-4, but not interleukin-10, is involved in suppression of host resistance against Listeria monocytogenes infection in gamma interferon-depleted mice. Infect. Immun. 64 (1996) 1252-1258
31. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162 (1987) 156-159
32. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501
33. Tracey K.J., and Abraham E. From mouse to man: or what have we learned about cytokine-based anti-inflammatory therapies?. Shock 11 (1999) 224-225
34. Asseman C., Mauze S., Leach M.W., Coffman R.L., and Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190 (1999) 995-1004
35. + cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion. J. Immunol. 171 (2003) 2270-2278
36. Katsikis P.D., Chu C.Q., Brennan F.M., Maini R.N., and Feldmann M. Immunoregulatory role of interleukin 10 in rheumatoid arthritis. J. Exp. Med. 179 (1994) 1517-1527
37. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
38. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., and Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282 (1998) 2085-2088
39. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
40. O'Neill L.A. Toll-like receptor signal transduction and the tailoring of innate immunity: a role for Mal?. Trends Immunol. 23 (2002) 296-300
41. Bogdan C., Rollinghoff M., and Diefenbach A. Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr. Opin. Immunol. 12 (2000) 64-76
42. Takeda K., Clausen B.E., Kaisho T., Tsujimura T., Terada N., Forster I., and Akira S. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity 10 (1999) 39-49
43. Neumann A., Schinzel R., Palm D., Riederer P., and Munch G. High molecular weight hyaluronic acid inhibits advanced glycation endproduct-induced NF-κB activation and cytokine expression. FEBS Lett. 453 (1999) 283-287